In today’s Pharma Pulse, Eli Lilly has launched the Employer Connect platform broadening access to Zepbound for U.S. workers, ...

In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...

Thermal testing can make or break cold chain performance. Join this webinar to learn proven best practices that help eliminate blind spots, validate designs, and protect temperature-sensitive ...

FDA authorized Tec-Dara for RRMM after ≥1 prior line (PI + IMiD exposure), accelerating earlier-line use where attrition and refractoriness erode response with successive regimens. A 55-day review ...

In today's Pharma Pulse, the FDA expands the pediatric indication for Juxtapid to treat rare homozygous familial hypercholesterolemia, while Novo Nordisk announces a major €432 million investment in ...

Esperion Therapeutics has entered into a definitive agreement to acquire Corstasis Therapeutics, a privately held biopharmaceutical company. The acquisition focuses on the integration of Enbumyst™ ...

SpotSee and Controlant announced a collaboration to enhance pharmaceutical supply chain visibility using integrated ...

West Asia–North Africa represented $1.75 billion of India’s FY25 pharma exports, dominated by finished dosage forms plus biosimilars and vaccines, with the UAE, Iraq, Egypt, and Saudi Arabia leading.

Thirty telehealth firms received warning letters for illegal promotion of compounded semaglutide/tirzepatide, reflecting an expanded enforcement tempo that now surpasses the prior decade’s letter ...

Global life sciences supply chain conference LogiPharma has announced a brand-new series of interactive formats for 2026 under the leadership of incoming event director, Ben Sharples.